Free Trial

STAAR Surgical (STAA) Competitors

$45.22
-1.89 (-4.01%)
(As of 07/15/2024 ET)

STAA vs. EYE, XRAY, MMSI, HAE, NEOG, ICUI, QDEL, ATRI, ANIK, and CERS

Should you be buying STAAR Surgical stock or one of its competitors? The main competitors of STAAR Surgical include National Vision (EYE), DENTSPLY SIRONA (XRAY), Merit Medical Systems (MMSI), Haemonetics (HAE), Neogen (NEOG), ICU Medical (ICUI), QuidelOrtho (QDEL), Atrion (ATRI), Anika Therapeutics (ANIK), and Cerus (CERS). These companies are all part of the "medical" sector.

STAAR Surgical vs.

STAAR Surgical (NASDAQ:STAA) and National Vision (NASDAQ:EYE) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.

STAAR Surgical has higher earnings, but lower revenue than National Vision. National Vision is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
STAAR Surgical$326.24M6.81$21.35M$0.31145.87
National Vision$2.13B0.47-$65.90M-$0.92-13.78

In the previous week, STAAR Surgical had 6 more articles in the media than National Vision. MarketBeat recorded 12 mentions for STAAR Surgical and 6 mentions for National Vision. National Vision's average media sentiment score of 1.01 beat STAAR Surgical's score of 0.89 indicating that National Vision is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STAAR Surgical
5 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
National Vision
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

STAAR Surgical currently has a consensus target price of $48.00, suggesting a potential upside of 6.15%. National Vision has a consensus target price of $19.60, suggesting a potential upside of 54.57%. Given National Vision's higher probable upside, analysts clearly believe National Vision is more favorable than STAAR Surgical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STAAR Surgical
1 Sell rating(s)
5 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.36
National Vision
0 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

STAAR Surgical received 34 more outperform votes than National Vision when rated by MarketBeat users. However, 65.89% of users gave National Vision an outperform vote while only 56.05% of users gave STAAR Surgical an outperform vote.

CompanyUnderperformOutperform
STAAR SurgicalOutperform Votes
287
56.05%
Underperform Votes
225
43.95%
National VisionOutperform Votes
253
65.89%
Underperform Votes
131
34.11%

STAAR Surgical has a net margin of 4.69% compared to National Vision's net margin of -3.44%. STAAR Surgical's return on equity of 6.83% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
STAAR Surgical4.69% 6.83% 5.45%
National Vision -3.44%3.47%1.33%

96.7% of STAAR Surgical shares are owned by institutional investors. 1.0% of STAAR Surgical shares are owned by company insiders. Comparatively, 2.3% of National Vision shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

STAAR Surgical has a beta of 0.59, suggesting that its stock price is 41% less volatile than the S&P 500. Comparatively, National Vision has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500.

Summary

STAAR Surgical beats National Vision on 12 of the 18 factors compared between the two stocks.

Get STAAR Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STAA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STAA vs. The Competition

MetricSTAAR SurgicalOphthalmic goods IndustryMedical SectorNASDAQ Exchange
Market Cap$2.31B$11.26B$5.30B$8.55B
Dividend YieldN/A1.63%5.26%4.03%
P/E Ratio145.8744.19132.4917.07
Price / Sales6.815.712,213.0180.77
Price / Cash64.3721.8232.4731.31
Price / Book5.723.714.954.54
Net Income$21.35M$224.33M$108.49M$214.94M
7 Day Performance4.92%0.33%5.62%5.07%
1 Month Performance9.70%-2.07%6.19%5.20%
1 Year Performance-19.69%-8.18%6.73%2.67%

STAAR Surgical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EYE
National Vision
3.726 of 5 stars
3.73 / 5 stars
$12.99
+7.2%
$19.60
+50.9%
-46.3%$952.16M$2.13B-14.1213,998Short Interest ↑
Gap Up
High Trading Volume
XRAY
DENTSPLY SIRONA
4.9431 of 5 stars
4.94 / 5 stars
$25.71
+5.3%
$34.33
+33.5%
-37.6%$5.07B$3.97B-58.4315,000Analyst Revision
MMSI
Merit Medical Systems
4.5789 of 5 stars
4.58 / 5 stars
$87.33
+0.2%
$96.20
+10.2%
+1.9%$5.07B$1.26B50.196,950Positive News
HAE
Haemonetics
3.82 of 5 stars
3.82 / 5 stars
$89.48
+2.8%
$109.50
+22.4%
+7.9%$4.44B$1.31B39.073,657Insider Selling
Short Interest ↑
NEOG
Neogen
2.3476 of 5 stars
2.35 / 5 stars
$16.21
+6.8%
$22.50
+38.8%
-27.7%$3.29B$822.45M1,622.122,640Gap Up
ICUI
ICU Medical
3.1717 of 5 stars
3.17 / 5 stars
$128.23
+4.3%
$127.00
-1.0%
-30.3%$3.00B$2.26B-52.3414,000Positive News
QDEL
QuidelOrtho
4.5526 of 5 stars
4.55 / 5 stars
$31.48
+5.1%
$59.00
+87.4%
-62.1%$2.01B$3.00B-1.197,100Insider Selling
ATRI
Atrion
3.6171 of 5 stars
3.62 / 5 stars
$453.63
-0.1%
N/A-17.1%$798.39M$176.67M42.63712Short Interest ↓
News Coverage
Positive News
ANIK
Anika Therapeutics
2.9576 of 5 stars
2.96 / 5 stars
$27.50
+5.0%
$30.50
+10.9%
+8.8%$401.23M$166.66M-5.24300Positive News
CERS
Cerus
2.6842 of 5 stars
2.68 / 5 stars
$2.11
+12.8%
$3.83
+81.7%
-11.2%$390.12M$156.37M-12.41625Short Interest ↑
Gap Up

Related Companies and Tools

This page (NASDAQ:STAA) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners